Presentation slides and videos from the 2025 Advances in Cancer Immunotherapy™ (ACI) Series: ACI Session at JADPRO Live 2025 were presented on October 23, 2025.
Program Organizers
Target Audience
The Advances in Cancer Immunotherapy™ (ACI) programs aim to reach practicing clinical oncologists, nurses, nurse practitioners, advanced practitioners, pharmacists, emergency physicians, and other allied health professionals who wish to learn the basic principles of cancer immunotherapy and the most up-to-date clinical data for these treatments, in a multitude of disease states/therapeutic areas, in order to inform and integrate into their own clinical practice. In-training oncologists and hospital administrators will also find the program beneficial.
Program Learning Objectives
You can view the program agenda here.
Please note on-demand recordings are not available for continuing education credits.
Meeting: 2025 Advances in Cancer Immunotherapy™ Series: ACI Session at JADPRO Live 2025; Presenter: Anecita Fadol PhD, APRN, FAANN, FAAN & Lisa Kottschade, APRN, MSN, CNP, FAPO; Date: October 23, 202500:22:03
Meeting: 2025 Advances in Cancer Immunotherapy™ Series: ACI Session at JADPRO Live 2025; Presenter: Marianne Davies, DNP, ACNP, AOCNP, FAAN; Date: October 23, 202500:29:21
Meeting: 2025 Advances in Cancer Immunotherapy™ Series: ACI Session at JADPRO Live 2025; Presenter: Beth Sandy, MSN, CRNP, FAPO; Date: October 23, 202500:25:37
Meeting: 2025 Advances in Cancer Immunotherapy™ Series: ACI Session at JADPRO Live 2025; Date: October 23, 202500:32:59